Ligand validation:3CL4

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3CL4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CL4_NAG_A_2523	85%	34%	0.101	0.967	1.15	1.43	1	2	0	0	100%	0.9333
3CL4_NAG_A_2521	59%	45%	0.139	0.921	0.57	1.54	-	4	0	0	100%	0.9333
3CL4_NAG_A_1961	34%	54%	0.206	0.891	0.48	1.27	-	1	0	0	100%	0.9333
3CL4_NAG_A_2527	22%	51%	0.246	0.863	0.54	1.33	-	1	1	0	100%	0.9333
3CL4_NAG_A_2520	6%	35%	0.287	0.724	0.81	1.72	-	3	0	0	100%	0.9333
3CL5_NAG_A_2521	67%	65%	0.123	0.932	0.45	0.88	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.